Antibody-based Protein Expression Analysis

Please refer to our previous publications (Xiao et al. 2019 (link); Cao et al. 2022 (link); Long et al. 2022 (link)).
Antibodies used were as follows: anti-THBS4 (Abcam ab263898, RRID: AB_2922811), anti-DCX (Abcam ab207175, RRID: AB_2894710), and anti-Ki67 (Abcam ab279653, RRID: AB_2934265).
For primer sequences, please see Supplemental Table S7.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Yang Q., Zhang L., Li M., Xu Y., Chen X., Yuan R., Ou X., He M., Liao M., Zhang L., Dai H., Lv M., Xie X., Liang W, & Chen X. (2023). Single-nucleus transcriptomic mapping uncovers targets for traumatic brain injury. Genome Research, 33(10), 1818-1832.

Publication 2023

ab263898 ab207175 ab279653

Corresponding Organization :

Other organizations : Sichuan University, West China Second University Hospital of Sichuan University, West China Medical Center of Sichuan University

Top 5 similar protocols

Variable analysis

independent variables

Antibodies used: anti-THBS4, anti-DCX, and anti-Ki67

dependent variables

Measured outcomes

control variables

Primer sequences, as provided in Supplemental Table S7

controls

Positive and negative controls not explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!